
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
Bhalchandra Mirlekar
SAGE Open Medicine (2022) Vol. 10
Open Access | Times Cited: 123
Bhalchandra Mirlekar
SAGE Open Medicine (2022) Vol. 10
Open Access | Times Cited: 123
Showing 26-50 of 123 citing articles:
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Effect of Periplaneta americana Residue Feed on Immunity, Antioxidant Capacity, and Transcriptome in Chickens: A Study on Sanhuang Chickens
Yongfei Zhao, Tianzhang Zhao, Shunyi Zi, et al.
Animals (2025) Vol. 15, Iss. 1, pp. 94-94
Open Access
Yongfei Zhao, Tianzhang Zhao, Shunyi Zi, et al.
Animals (2025) Vol. 15, Iss. 1, pp. 94-94
Open Access
The distinct characteristic of two peritoneal macrophage subsets in a mouse model of hepatocellular carcinoma presents a novel therapeutic strategy
Wanli Yang, Chao Yang, Nan Pang, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104917-104917
Open Access
Wanli Yang, Chao Yang, Nan Pang, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104917-104917
Open Access
The effects of autophagy-modifying drugs chloroquine and lithium on the skin melanoma microenvironment
Iuliia Taskaeva, Anastasia Shatruk, Igor Ivanov, et al.
Tissue and Cell (2025) Vol. 93, pp. 102753-102753
Closed Access
Iuliia Taskaeva, Anastasia Shatruk, Igor Ivanov, et al.
Tissue and Cell (2025) Vol. 93, pp. 102753-102753
Closed Access
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Research Advances in the Pathogenesis of Inflammatory Factors and Adenomyosis
丽 杨
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1303-1310
Closed Access
丽 杨
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1303-1310
Closed Access
The ubiquitin ligase Pellino1 targets STAT3 to regulate macrophage-mediated inflammation and tumor development
Soeun Hwang, Junhee Park, Seo-Young Koo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Soeun Hwang, Junhee Park, Seo-Young Koo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Immunomodulatory Effects of Atractylodes lancea in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach
Teerachat Saeheng, Juntra Karbwang, K Na‐Bangchang
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 198-198
Open Access
Teerachat Saeheng, Juntra Karbwang, K Na‐Bangchang
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 198-198
Open Access
Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Reprogramming the Tumor Immune Microenvironment with ICAM‐1‐Targeted Antibody‒Drug Conjugates and B7‐H3‐CD3 Bispecific Antibodies
Shoubing Zhou, Mengyu Hong, Dan Zhao, et al.
Advanced Science (2025)
Open Access
Shoubing Zhou, Mengyu Hong, Dan Zhao, et al.
Advanced Science (2025)
Open Access
Vascular endothelial growth factor released from lenvatinib‐resistant hepatocellular carcinoma promotes malignant behavior and drug resistance through tumor‐associated macrophages
Yukako Takehara, Yuhei Waki, Yuji Morine, et al.
Hepatology Research (2025)
Closed Access
Yukako Takehara, Yuhei Waki, Yuji Morine, et al.
Hepatology Research (2025)
Closed Access
Therapeutic potential of isochlorogenic acid A from Taraxacum officinale in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer
Tianyun Wang, Jingwei Sun, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tianyun Wang, Jingwei Sun, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, et al.
Oncogene (2025)
Open Access
Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, et al.
Oncogene (2025)
Open Access
Battlegrounds of treatment resistance: decoding the tumor microenvironment
Mobina Bayat, Javid Sadri Nahand
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mobina Bayat, Javid Sadri Nahand
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by Hashimoto’s thyroiditis
Xiaohui Xue, Deqi Wu, Hongwen Yao, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Xiaohui Xue, Deqi Wu, Hongwen Yao, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment
Tithi Bhattacharyya, Pritam Das, Aasia Ansari, et al.
ACS Applied Bio Materials (2025)
Closed Access
Tithi Bhattacharyya, Pritam Das, Aasia Ansari, et al.
ACS Applied Bio Materials (2025)
Closed Access
Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC)
Rakesh Kumar, Kamal Jain, Shashi Raj K, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Rakesh Kumar, Kamal Jain, Shashi Raj K, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, et al.
Translational Oncology (2023) Vol. 38, pp. 101799-101799
Open Access | Times Cited: 12
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, et al.
Translational Oncology (2023) Vol. 38, pp. 101799-101799
Open Access | Times Cited: 12
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang‐Yun Lee, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 4, pp. 857-876
Open Access | Times Cited: 11
Jeong Uk Lim, Eunyoung Lee, Sang‐Yun Lee, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 4, pp. 857-876
Open Access | Times Cited: 11
Immunostimulatory effects of thermal ablation: Challenges and future prospects
Peng Liu, Zhigang Wei, Xin Ye
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 531-539
Open Access | Times Cited: 4
Peng Liu, Zhigang Wei, Xin Ye
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 531-539
Open Access | Times Cited: 4
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation – a comprehensive review
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Future Oncology (2022) Vol. 18, Iss. 29, pp. 3349-3365
Closed Access | Times Cited: 18
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Future Oncology (2022) Vol. 18, Iss. 29, pp. 3349-3365
Closed Access | Times Cited: 18
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 3
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 3
CD47-mediated immune evasion in early-stage lung cancer progression
Cheng‐Hao Chuang, Yen‐Yi Zhen, Juei-Yang Ma, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 720, pp. 150066-150066
Closed Access | Times Cited: 3
Cheng‐Hao Chuang, Yen‐Yi Zhen, Juei-Yang Ma, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 720, pp. 150066-150066
Closed Access | Times Cited: 3